Health
Pfizer aims for $15bn in 2021 COVID-19 vaccine sales – PMLiVE
Current estimate is based on already agreed contracts
Pfizer has forecast major sales expectations for its BioNTech-partnered COVID-19 vaccine, BNT162b2, in its fourth quarter results – aiming for approximately $15bn in revenues for 2021.
The company said that the 2021 guidance for the vaccine mainly includes doses that are expected to be delivered in the year under existing contracts, adding that it may be adjusted dependent on future additional contracts.
In the fourth quarter of 2020 alone BNT162b2 contributed $154m to Pfizer’s overall sales.
For…
-
General20 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General23 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News22 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
General21 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience